Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Merck Sharp & Dohme Limited
Hertford Road, Hoddesdon, Hertfordshire, EN11 9BU
Telephone: +44 (0)1992 467 272
Fax: +44 (0)1992 479 292
Medical Information e-mail: medicalinformationuk@merck.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 21/02/2012
PIL INVANZ 1g powder for concentrate for solution for infusion

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 21/02/2012 and displayed until Current
Reasons for adding or updating:
  • Change to Further Information section
Updated on 13/01/2012 and displayed until 21/02/2012
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
Updated on 11/08/2010 and displayed until 13/01/2012
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 09/11/2009 and displayed until 11/08/2010
Reasons for adding or updating:
  • Change to drug interactions
Updated on 10/09/2009 and displayed until 09/11/2009
Reasons for adding or updating:
  • Change to side-effects
Updated on 09/01/2009 and displayed until 10/09/2009
Reasons for adding or updating:
  • Change to side-effects
  • Change to MA holder contact details
Updated on 18/06/2007 and displayed until 09/01/2009
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 20/11/2006 and displayed until 18/06/2007
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 10/11/2006 and displayed until 20/11/2006
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 27/09/2006 and displayed until 10/11/2006
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to dosage and administration
  • Change to side-effects
Updated on 31/01/2006 and displayed until 27/09/2006
Reasons for adding or updating:
  • Change to, or new, use for medicine
Updated on 28/09/2005 and displayed until 31/01/2006
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to how to administer the medicine
Updated on 05/08/2004 and displayed until 28/09/2005
Reasons for adding or updating:
  • Change to packaging
Updated on 08/07/2004 and displayed until 05/08/2004
Reasons for adding or updating:
  • Change to packaging
Updated on 20/01/2004 and displayed until 08/07/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 27/09/2002 and displayed until 20/01/2004
Reasons for adding or updating:
  • New PIL for new product
Updated on 18/09/2002 and displayed until 27/09/2002
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  ertapenem